Quantification of minimal residual disease in children with oligoclonal B-precursor acute lymphoblastic leukemia indicates that the clones that grow out during relapse already have the slowest rate of reduction during induction therapy

✍ Scribed by de Haas, V; Verhagen, O J H M; von dem Borne, A E G Kr; Kroes, W; van den Berg, H; van der Schoot, C E

• Book ID: 110054742
• Publisher: Nature Publishing Group
• Year: 2001
• Tongue: English
• Weight: 179 KB
• Volume: 15
• Category: Article
• ISSN: 0887-6924
• DOI: 10.1038/sj.leu.2401970